St Pharm Co (XKRX:237690) Cyclically Adjusted Book per Share: ₩ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:237690 St Pharm Co Ltd XKRX:237690
95 GF Score
Price ₩92,700.00
GF Value ₩115,775.72
Valuation Modestly Undervalued
View Full Analysis

What is St Pharm Co Cyclically Adjusted Book per Share?

St Pharm Co XKRX:237690 +0.87% 95 Cyclically Adjusted Book per Share is ₩ as of Jun. 2026. GuruFocus rates XKRX:237690 with a GF Score™ of 95/100 and a GF Value™ of ₩115,775.72 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

St Pharm Co's adjusted book value per share for the three months ended in Jun. 2026 was ₩30,132.765. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, St Pharm Co's average Cyclically Adjusted Book Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-21), St Pharm Co's current stock price is ₩92700.00. St Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was . St Pharm Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of St Pharm Co was 7.68. The lowest was 3.66. And the median was 4.76.


St Pharm Co  (XKRX:237690) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of St Pharm Co was 7.68. The lowest was 3.66. And the median was 4.76.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


St Pharm Co Cyclically Adjusted Book per Share Related Terms


St Pharm Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for St Pharm Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

St Pharm Co Cyclically Adjusted Book per Share Chart

St Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

St Pharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

XKRX:237690 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


St Pharm Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where St Pharm Co's Cyclically Adjusted PB Ratio falls into.


XKRX:237690
95GF Score
St Pharm Co Ltd XKRX:237690
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

St Pharm Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, St Pharm Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=30132.765/126.4904*126.4904
=30,132.765

Current CPI (Jun. 2026) = 126.4904.

St Pharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 16,335.211 101.461 20,364.902
201612 16,946.435 101.561 21,106.084
201703 17,152.239 102.851 21,094.613
201706 17,915.473 102.611 22,084.657
201709 18,342.963 103.491 22,419.533
201712 18,818.760 102.991 23,112.671
201803 18,364.323 104.101 22,314.051
201806 18,629.703 104.130 22,630.095
201809 18,271.685 105.651 21,875.833
201812 17,772.779 104.351 21,543.563
201903 16,992.837 104.491 20,570.507
201906 16,832.886 104.881 20,301.108
201909 16,810.139 105.200 20,212.121
201912 16,277.863 105.121 19,586.834
202003 16,113.317 105.354 19,345.977
202006 16,219.315 105.112 19,518.148
202009 15,833.710 106.198 18,859.299
202012 15,906.583 105.765 19,023.519
202103 15,622.612 107.357 18,406.874
202106 15,968.596 107.579 18,775.798
202109 16,500.268 108.759 19,190.335
202112 17,334.068 109.676 19,991.477
202203 16,906.541 111.848 19,119.833
202206 17,200.093 114.072 19,072.524
202209 17,888.772 114.715 19,724.988
202212 18,135.311 115.179 19,916.293
202303 17,890.585 116.507 19,423.550
202306 18,105.944 117.182 19,544.180
202309 20,147.865 118.964 21,422.616
202312 20,570.527 118.837 21,895.302
202403 20,810.659 120.123 21,913.740
202406 22,002.321 120.007 23,190.942
202409 24,349.350 120.861 25,483.439
202412 24,958.765 121.135 26,062.153
202503 24,527.327 122.590 25,307.704
202506 24,832.707 122.611 25,618.391
202509 26,862.333 123.402 27,534.687
202512 28,645.191 123.939 29,234.808
202603 29,332.894 125.236 29,626.701
202606 30,132.765 126.490 30,132.765

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₩ mean?
St Pharm Co (XKRX:237690) has a Cyclically Adjusted Book per Share of ₩ as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on St Pharm Co and its competitors.
Is St Pharm Co's Cyclically Adjusted Book per Share too high?
St Pharm Co's current Cyclically Adjusted Book per Share is ₩. Overall, St Pharm Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's Cyclically Adjusted Book per Share compare to ZTS?
St Pharm Co's Cyclically Adjusted Book per Share of ₩ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on St Pharm Co and its competitors. St Pharm Co's current Cyclically Adjusted Book per Share is ₩. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₩. St Pharm Co's overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current Cyclically Adjusted Book per Share is ₩ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is St Pharm Co (XKRX:237690) Overvalued in 2026?

Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued. The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72. GuruFocus considers St Pharm Co to be Modestly Undervalued.

Key valuation signals for XKRX:237690:

  • Cyclically Adjusted Book per Share:
  • GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


St Pharm Co Business Description

Address Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
95GF Score

Get the complete analysis for XKRX:237690

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩92,700.00
Price
₩115,775.72
GF Value